Session Type
Meeting
Search Results for Oral
Abstract Number: B1
SHM Converge 2022
Background: Use of stigmatizing language in clinical note documentation is a recognized problem, but such notes may be viewed disparately and irregularly. Whether such language is also used in highly visible behavioral alerts (BAs), which are presented forcefully through push notifications and viewed repeatedly whenever a chart is opened, is unknown. Further, whether BAs with […]
Abstract Number: D3
SHM Converge 2022
Background: Communication with consultant teams is critical to the hospitalist workflow, especially in hospitals with multiple levels of hierarchy due to varying training backgrounds and experiences. We aimed to increase knowledge of the communication dynamic between hospitalists and consultant attendings in medical and surgical specialties. Methods: We surveyed Emory Division of Hospital Medicine physicians and Advanced Practice Providers to assess interactions with consultant attendings. Surveys […]
Abstract Number: H8
SHM Converge 2022
Background: Role of vitamin K antagonist (VKA) or Direct Oral anticoagulation (DOAC) for non-valvular atrial fibrillation has widely been discussed. But the literature on anticoagulation therapy for patients with valvular atrial fibrillation (VAF) is limited. Aim of this meta-analysis was to evaluate the outcomes (stroke-vascular events and intracranial bleeding) following DOAC and VKA amongst patients […]
Abstract Number: I4
SHM Converge 2022
Background: Diabetes is an exceedingly common disease encountered by medical trainees, with over 8 million hospitalizations in 2018 listing type 1 or type 2 diabetes as a diagnosis (1). Evidence supports continuing certain oral diabetes medications during admission when safe, reflected in recent consensus statements from professional societies (2,3). Nevertheless, oral medications are often held […]
Abstract Number: P4
SHM Converge 2022
Background: Hospitalists routinely precept third year medical students on general internal medicine wards. One of the key patient care tasks for students is to present and interpret common laboratory test abnormalities. Formal training in interpreting routine diagnostic tests is lacking for students transitioning from preclinical to clinical years. We designed and implemented a module on […]
Abstract Number: 109
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Background: The number of individuals with Alzheimer’s disease and related dementias (ADRD) in the U.S is projected to reach 16 million by 2050. Currently, they account for 3.2 million hospital admissions per year and over 75% of hospitalized persons with ADRD display Behavioral and Psychological Symptoms of Dementia (BPSD). The study aimed to evaluate management […]
Abstract Number: 118
SHM Converge 2024
Background: Pneumocystis pneumonia (PCP) is a life-threatening opportunistic infection that leads to severe pneumonia in immunocompromised hosts. This results in respiratory failure and hypoxemia. Its reported survival rate ranges from 20% to 50%. Despite its seriousness, there is limited research on the occurrence of PCP in children, likely due to its infrequency. Current national data […]
Abstract Number: 129
Hospital Medicine 2018; April 8-11; Orlando, Fla.
Background: Over 6 million people in the US have a diagnosis of atrial fibrillation. Given the increased risk for stroke and systemic embolism, many patients are treated with direct oral anticoagulants (DOACs) to reduce their risk. In the major trials comparing to DOACs to warfarin for stroke and systemic embolism prevention in atrial fibrillation, DOACs […]
Abstract Number: 129
Hospital Medicine 2020, Virtual Competition
Background: Cancer-associated thrombosis (CAT) is a common complication in patients with malignancy. Management of venous thromboembolism (VTE), in these patients, is challenging due to the high risk of recurrence and inherent risk of bleeding in this population. Direct oral anticoagulants (DOACs) have emerged as a treatment options for CAT. As yet there have not been […]
Abstract Number: 145
Hospital Medicine 2018; April 8-11; Orlando, Fla.
Background: Venous thromboembolism (VTE) in hospitalized medically ill patients is a leading preventable cause of morbidity and mortality in the United States. About half of VTE events occur following discontinuation of standard-duration in-hospital prophylaxis and hospital discharge. The APEX study evaluated Betrixaban for in-hospital to home VTE prophylaxis and is the first FDA approved anticoagulant […]